This feature examines why India‘s patenting regime, despite being pro-public in terms of promoting easier access to drugs, has faced considerable criticism, particularly post the Supreme Court decision in the Novartis case. The feature examines why India has… Continue Reading →
© 2024 Kractivism — Powered by WordPress
Theme by Anders Noren — Up ↑